Amyloid beta peptides start out as helpful scaffolding, but they can turn toxic with the production of reactive oxygen ...

Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...

New research has revitalized interest in the longstanding link between brain trauma and dementia by focusing on the vascular ...

Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.

Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...

TOKYO, Feb 14, 2025 - (JCN Newswire) - - Oita University and Eisai Co., Ltd. (Eisai) announced today the development of a machine learning model to predict amyloid beta(1)(Abeta) accumulation in ...